Comments: OK HB3834 | 2026 | Regular Session
Bill Title: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Sponsorship: Partisan Bill (Republican 3)
Status: (Passed) 2026-05-12 - Approved by Governor 05/12/2026 [HB3834 Detail]
Text: Latest bill text (Enrolled) [PDF]
Sponsorship: Partisan Bill (Republican 3)
Status: (Passed) 2026-05-12 - Approved by Governor 05/12/2026 [HB3834 Detail]
Text: Latest bill text (Enrolled) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2026 Oklahoma HB3834 at this time. | |||||
